Systemic Therapy in Metastatic Castration-Resistant Prostate Cancer
Journal Title: Nükleer Tıp Seminerleri - Year 2018, Vol 4, Issue 3
Abstract
Prostate cancer is the second leading cause of cancer death in men. Tumor growth and progression are androgen-dependent; for this reason, androgen deprivation therapy has been the main therapeutic intervention for treatment of prostate cancer. However, the disease becomes castration-resistant after a period of time. In castration-resistant prostate cancer, the most common metastatic sites are bones and lymph nodes. Metastatic castration-resistant prostate cancer is a fatal disease requiring systemic treatment. Chemotherapy, hormonal therapy, immunotherapy, and radionuclide therapy can be used to achieve control of the disease.
Authors and Affiliations
Özgecan Dülgar, Mesut Yılmaz, Deniz Tural
Keywords
Related Articles
- EP ID EP421373
- DOI 10.4274/nts.2018.025
- Views 109
- Downloads 0
Basic Concepts in Intervention of Nuclear, Radiological Injuries, Acute Radiation Syndrome and Its Treatment
Acute radiation syndrome or acute radiation sickness is a term used to describe a constellation of signs and symptoms that occurs after whole-body or significant partial-body irradiation of certain amount of radiation (>...
Radiation Detection and Measurement
Radiation is not a phenomenon that can be sensed, it is invisible, inaudible, imperceptible, and it cannot be perceived by contact. In cases of diagnosis, treatment, radiation protection, and possible radiation accidents...
Positron Emission Tomography/Computed Tomography in Mediastinal Masses
Mediastinum can comprise a wide diversity of malign and benign tumors. Thymus tumors, lymphomas, germ cell tumors, thyroid and parathyroid masses, metastasis, and neurogenic tumors are the common tumors detected in the m...
FDG PET/CT Imaging for Evaluation of Treatment Response in Lung Cancer
Lung cancer is the most common cause of cancer-related mortality worldwide. Surgery, radiation therapy, systemic chemotherapy, and biological therapy are the modalities used to treat lung cancer. Despite recognized limit...
Positron Emission Tomography/Magnetic Resonanse Imaging Applications in Neurologic Imaging
Hybrid positron emission tomography/magnetic resonance imaging (PET/MRI) systems allow simultaneous assessment of disease-related structural and functional changes that occur in neurological disorders. Diagnostic use of...